Literature DB >> 20010872

Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization.

A Sirvent1, C Bénistant, J Pannequin, L Veracini, V Simon, J-F Bourgaux, F Hollande, F Cruzalegui, S Roche.   

Abstract

The nonreceptor tyrosine kinases of the Src family (SFK) are frequently deregulated in human colorectal cancer (CRC), and they have been implicated in tumour growth and metastasis. How SFK are activated in this cancer has not been clearly established. Here, we show that the SFK-dependent invasion is induced by inactivation of the negative regulator C-terminal Src kinase, Csk. While the level of Csk was inconsistent with SFK activity in colon cancer cells, its membrane translocation, needed for efficient regulation of membrane-localized SFK activity, was impaired. Accordingly, Csk downregulation did not affect SFK oncogenic activity in these cells, whereas expression of a membrane-localized form of this kinase affected their invasive activity. Downregulation of the transmembrane and rafts-localized Csk-binding protein/phosphoprotein associated with glycosphingolipid-enriched microdomain (PAG), was instrumental for the cytoplasmic accumulation of Csk. Re-expression of PAG in cells from late-stage CRC inhibited SFK invasive activity in a Csk-dependent manner. Conversely, inactivation of its residual expression in early-stage CRC cells promoted SFK invasive activity. Finally, this mechanism was specific to CRC as Csk coupling to SFK was readily detected in breast cancer cells. Therefore, Csk mis-localization defines a novel mechanism for SFK oncogenic activation in CRC cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20010872     DOI: 10.1038/onc.2009.450

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

1.  Integration of genetic signature and TNM staging system for predicting the relapse of locally advanced colorectal cancer.

Authors:  Junjie Peng; Zhimin Wang; Wei Chen; Yin Ding; Haifeng Wang; Hongjie Huang; Wei Huang; Sanjun Cai
Journal:  Int J Colorectal Dis       Date:  2010-08-13       Impact factor: 2.571

2.  Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling.

Authors:  Liudmilla Rubbi; Björn Titz; Lauren Brown; Erica Galvan; Evangelia Komisopoulou; Sharon S Chen; Tracey Low; Martik Tahmasian; Brian Skaggs; Markus Müschen; Matteo Pellegrini; Thomas G Graeber
Journal:  Sci Signal       Date:  2011-03-29       Impact factor: 8.192

3.  Analysis of SRC oncogenic signaling in colorectal cancer by stable isotope labeling with heavy amino acids in mouse xenografts.

Authors:  Audrey Sirvent; Oana Vigy; Beatrice Orsetti; Serge Urbach; Serge Roche
Journal:  Mol Cell Proteomics       Date:  2012-09-29       Impact factor: 5.911

4.  Targeted Quantitative Kinome Analysis Identifies PRPS2 as a Promoter for Colorectal Cancer Metastasis.

Authors:  Weili Miao; Yinsheng Wang
Journal:  J Proteome Res       Date:  2019-04-02       Impact factor: 4.466

5.  Cooperative role of caveolin-1 and C-terminal Src kinase binding protein in C-terminal Src kinase-mediated negative regulation of c-Src.

Authors:  Aaron T Place; Zhenlong Chen; Farnaz R Bakhshi; Guoquan Liu; John P O'Bryan; Richard D Minshall
Journal:  Mol Pharmacol       Date:  2011-07-21       Impact factor: 4.436

6.  Progastrin a new pro-angiogenic factor in colorectal cancer.

Authors:  S Najib; A Kowalski-Chauvel; C Do; S Roche; E Cohen-Jonathan-Moyal; C Seva
Journal:  Oncogene       Date:  2014-08-11       Impact factor: 9.867

7.  Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer.

Authors:  Audrey Sirvent; Christine Benistant; Serge Roche
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

8.  YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cells.

Authors:  Fanny Dubois; Cédric Leroy; Valérie Simon; Christine Benistant; Serge Roche
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

9.  Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.

Authors:  Chad D Walls; Anton Iliuk; Yunpeng Bai; Mu Wang; W Andy Tao; Zhong-Yin Zhang
Journal:  Mol Cell Proteomics       Date:  2013-09-12       Impact factor: 5.911

10.  Characterization of TRIP6-dependent nasopharyngeal cancer cell migration.

Authors:  Jie Fei; Jihong Li; Sunan Shen; Weidong Zhou
Journal:  Tumour Biol       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.